Challenges and Perspectives for Swine Viral Vaccines
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Veterinary Vaccines".
Deadline for manuscript submissions: closed (1 December 2023) | Viewed by 1728
Special Issue Editors
Interests: virus vaccine; veterinary virology; molecular cloning
Interests: porcine coronaviruses; porcine circoviruses; senecavirus A; emerging viruses
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Infections of swine viruses are responsible for significant economic losses in the pork industry worldwide. Vaccination is an important strategy to protect swine against virus diseases. One of the biggest problems in vaccinology is the rapid genetic changes or the evolution of viruses. Human viral vaccine technologies are rapidly developed, as are the delivery systems and new antigenic epitopes. However, the development of swine viral vaccine either in term of technologies or novel antigenic epitopes which are able to broadly prevent viral infection and induce humoral and cellular immune responses is infrequently studied. Therefore, we would like to compile the challenges and perspectives for swine viral vaccines and the development of swine viral vaccine together with their immunogenicity and efficacies in this Special Issue.
Dr. Saeng-Chuto Kepalee
Dr. Gun Temeeyasen
Dr. Anbu Kumar Karuppannan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- swine viral vaccines
- development
- vaccine technologies
- prevention
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.